Technology×Healthcare 2019

※Japanese only, no English translation


As announced in its Corporate Strategic Plan 2018 based on its vision “On the forefront of healthcare change to turn innovative science into value for patients”, Astellas is committed to “Developing Rx+TM (1) programs,” which aims to create new healthcare solutions (Rx+TM) that combine expertise and experience cultivated through the prescription drug (Rx) business with attractive seeds from different fields.

As a part of such efforts, in this fiscal year we are implementing the accelerator programs in "Tech ARINA (2)" to match the technologies of the Tokyo Institute of Technology (Tokyo Tech) with our medical knowledge and experience. We will hold this symposium to let everyone know about our latest efforts for the challenge to evolution which may be realized by connecting healthcare and technology. Also, we would like to talk about the healthcare in the future with the visitors.
Click here for the Technology×Healthcare 2018 held last year. ※Japanese only, no English translation

(1) Rx+TM creates new patient values on every “Patient Journey” that combines our expertise and experiences with technology and knowledge from different fields to build new revenue streams separate from our core Rx products

(2) Tech ARINA: It stands for Tokyo Tech-Astellas Rx+ INnovation Award. Idea contest for healthcare research themes using science and technology related to Astellas' wish list is held, and joint research on accelerator programs will be conducted between Tokyo Tech and Astellas for social implementation of selected ideas.


Name of the Event: Technology×Healthcare 2019 -The Challenge to Evolution:  Connection between Healthcare and Technology-
Date: December 23rd, 2019 14:00-19:30 (start accepting: 13: 30)

Kuramae Hall on the 1st floor of Tokyo Tech Front
(Networking & Reception: Royal Blue Hole in Tokyo Tech Front)
2-12-1, Ookayama, Meguro-ku, Tokyo, Japan

Target participants: People who are interested in the collaboration of technology and healthcare  (students are welcome)
Capacity: 300 people (If the number of applicants exceeds the limit, we will draw lots.)
Participation fees: Free of charge (prior application is needed)
Sponsorship: Co-sponsored by Tokyo Institute of Technology / Innovations and Future Creation Inc. (MIRAI SOUZOU) / Astellas Pharma Inc.

※Japanese only, no English translation


Time Contents Speaker Title
14:00 - 14:10 Opening Remarks 1 Astellas Pharma Inc.
Representative Director, President and CEO
Kenji Yasukawa, Ph.D.
Developing Rx+TM Programs
~ Creation of new healthcare solution ~
14:10 - 14:20 Opening Remarks 2 Tokyo Institute of Technology
Kazuya Masu
Advanced Technology & Challenges by Tokyo Tech
14:20 ‐ 15:25 Session1 Chairperson
Astellas Pharma Inc.
Senior Vice President, Rx+ Business Accelerator
Yuta Watanabe
Activities of Astellas' Rx+ Business Accelerator
14:25 - 14:45   Astellas Pharma Inc.
Rx+ Business Accelerator
Kohsuke Shakushiro
Rx+ StoryTM
~ A world realized by Rx+TM ~
14:45 - 15:05   Astellas Pharma Inc.
Rx+ Business Accelerator
Motohiro Kanayama
15:05 - 15:25   Moff Inc.
Akinori Takahagi
Rehabilitation and exercise support 
using wearable and motion capture technology
15:25 - 15:35 Bio Break    
15:35 - 16:40 session2 Chairperson
Innovations and Future Creation Inc. (MIRAI SOUZOU)
Hiroyuki Okada
Forefront of Overseas Health Tech Start-ups
15:40 - 16:00   Astellas Pharma Inc.
Rx+ Business Accelerator
Sumiho Nakatsu
A Look into HealthTech Scene in Silicon Valle
16:00 - 16:20   Aniwo Ltd.
Head of Japan, Executive Officer Business Development
Eiji Matsuyama
The Israel Healthcare startups~the boom is coming~
16:20 - 16:40   Deloitte Tohmatsu Consulting LLC
Takeshi Yanagimoto
Evolving Digital Health in China : How we can leverage this trend?
16:40 - 16:50 Bio Break    
16:50 - 18:20 Session3 Chairperson
Astellas Pharma Inc.
Rx+ Business Accelerator
Tatsuhisa Takahashi
Tech ARINA, The project to search for engineering seeds that matches healthcare
17:00-17:20   Tokyo Institute of Technology
Fujie Group, School of Life Science and Technology
Hajime Fujita
Body-conformable and battery-free, wireless wearable device
17:20-17:40   Tokyo Institute of Technology
Department of Mechanical Engineering, School of Engineering
Associate Professor
Tohru Yagi
Research and development on bio-hybrid prosthetic hand using neural regeneration
17:40-18:00   Tokyo Institute of Technology
Department of Computer Science of Technology
Associate Professor
Masahiro Takinoue
Innovative healthcare opened up by molecular robot technology -toward tiny programmable robots that can perform diagnosis and treatment in the body-
18:00-18:20   Tokyo Institute of Technology
Department of Chemical Science and Engineering, School of Materials and Chemical Technology
Associate Professor
Keita Yamada
Non-invasive detection of blood glucose levels based on natural isotopic signature of breath acetone
18:20 - 18:25 Closing Remarks 1 Tokyo Institute of Technology
Executive Vice President for Research
Osamu Watanabe
18:25 - 18:30 Closing Remarks 2 Astellas Pharma Inc.
Representative Director, Corporate Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO)
Naoki Okamura
18:30 - 19:30 Networking, Reception    


If you are interested in this symposium, please contact to [email protected]

Contact the Media Relations team
Communications & Investor Relations
Main phone line for Media: +81-3244-3201 
Business hours (JST)
From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm
(closed on Saturdays, Sundays, national holidays and company holidays)